Published in Endocr Rev on April 14, 2009
Mammalian genes induce partially reprogrammed pluripotent stem cells in non-mammalian vertebrate and invertebrate species. Elife (2013) 1.49
Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent. Stem Cells Transl Med (2012) 1.24
Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. J R Soc Interface (2010) 1.06
Stem cell banking: between traceability and identifiability. Genome Med (2010) 1.04
Stem cell therapy for cerebral ischemia: from basic science to clinical applications. J Cereb Blood Flow Metab (2012) 1.03
Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology. J Cell Mol Med (2011) 1.03
From banking to international governance: fostering innovation in stem cell research. Stem Cells Int (2011) 0.93
The Rho kinase inhibitor Y-27632 facilitates the differentiation of bone marrow mesenchymal stem cells. J Mol Histol (2014) 0.88
Clinical and experimental advances in regeneration of spinal cord injury. J Tissue Eng (2010) 0.87
Hydrogel formulation determines cell fate of fetal and adult neural progenitor cells. Stem Cell Res (2013) 0.87
Myelin damage and repair in pathologic CNS: challenges and prospects. Front Mol Neurosci (2015) 0.83
What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury? BMC Neurol (2011) 0.81
Stem cell trials for cardiovascular medicine: ethical rationale. Tissue Eng Part A (2013) 0.79
Generation of human epidermis-derived mesenchymal stem cell-like pluripotent cells (hEMSCPCs). Sci Rep (2013) 0.78
Myocardial infarction and stem cells. J Pharm Bioallied Sci (2011) 0.77
Combined use of N-acetylcysteine and Liberase improves the viability and metabolic function of human hepatocytes isolated from human liver. Cytotherapy (2014) 0.77
Stem cell therapy in spinal cord injury: Hollow promise or promising science? J Craniovertebr Junction Spine (2016) 0.76
Recent developments in β-cell differentiation of pluripotent stem cells induced by small and large molecules. Int J Mol Sci (2014) 0.76
Recent Advances in Stem Cell-Based Therapeutics for Stroke. Transl Stroke Res (2016) 0.76
Science and ethics: bridge to the future for regenerative medicine. Int J Stem Cells (2011) 0.75
Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke. Transl Stroke Res (2017) 0.75
Characterization and genetic manipulation of primed stem cells into a functional naïve state with ESRRB. World J Stem Cells (2016) 0.75
The Future of Ethics in Medicine. Iran Red Crescent Med J (2016) 0.75
Mesenchymal Stem and Progenitor Cells in Regeneration: Tissue Specificity and Regenerative Potential. Stem Cells Int (2017) 0.75
Prospects for regenerative medicine approaches in women's health. J Anat (2015) 0.75
PERIPHERAL NERVE REGENERATION: CELL THERAPY AND NEUROTROPHIC FACTORS. Rev Bras Ortop (2015) 0.75
Direct reprogramming and biomaterials for controlling cell fate. Biomater Res (2016) 0.75
Modeling Human Neurological and Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Neuronal Differentiation and Its Applications in Neurotrauma. Front Mol Neurosci (2017) 0.75
An overview on ethical considerations in stem cell research in Iran and ethical recommendations: A review. Int J Reprod Biomed (Yazd) (2017) 0.75
Stem cells in dentistry: knowledge and attitude of Nigerian dentists. BMC Oral Health (2013) 0.75
Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson's Disease. Sci Rep (2016) 0.75
Ethical considerations in tissue engineering research: Case studies in translation. Methods (2015) 0.75
[Corneal cell therapy-an overview]. Ophthalmologe (2017) 0.75
Cellular reprogramming for clinical cartilage repair. Cell Biol Toxicol (2017) 0.75
Cancer Is to Embryology as Mutation Is to Genetics: Hypothesis of the Cancer as Embryological Phenomenon. ScientificWorldJournal (2017) 0.75
Induced Pluripotent Stem Cell Neuronal Models for the Study of Autophagy Pathways in Human Neurodegenerative Disease. Cells (2017) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Disease-specific induced pluripotent stem cells. Cell (2008) 16.95
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature (2009) 11.27
Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med (2001) 9.51
Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature (2009) 9.29
Ethics. Identifiability in genomic research. Science (2007) 9.08
Thinking about the human neuron mouse. Am J Bioeth (2007) 6.98
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol (2003) 6.21
Genetics. No longer de-identified. Science (2006) 6.20
Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet (2001) 6.07
Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol (2008) 5.24
Research ethics and the challenge of whole-genome sequencing. Nat Rev Genet (2008) 4.03
Informed consent and federal funding for stem cell research. Hastings Cent Rep (2008) 3.09
Therapeutic misconception and the appreciation of risks in clinical trials. Soc Sci Med (2004) 2.97
New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell (2008) 2.61
A model designed to enhance informed consent: experiences from the HIV prevention trials network. Am J Public Health (2005) 1.89
Fair payment or undue inducement? Nature (2006) 1.81
Embryonic stem cells. Willingness to donate frozen embryos for stem cell research. Science (2007) 1.75
Obtaining consent for future research with induced pluripotent cells: opportunities and challenges. PLoS Biol (2009) 1.58
Human cloning - the science and ethics of nuclear transplantation. N Engl J Med (2004) 1.47
Zygote and "clonote"--the ethical use of embryonic stem cells. N Engl J Med (2004) 1.42
Uncertain benefit: investigators' views and communications in early phase gene transfer trials. Mol Ther (2004) 1.26
Gene therapy. As Gelsinger case ends, gene therapy suffers another blow. Science (2005) 1.16
Payment for egg donation and surrogacy. Mt Sinai J Med (2004) 1.09
Contested commodities at both ends of life: buying and selling gametes, embryos, and body tissues. Kennedy Inst Ethics J (2001) 1.06
Medicine. Consent from donors for embryo and stem cell research. Science (2003) 1.05
Stem cells. How young Korean researchers helped unearth a scandal ... Science (2006) 1.04
A follow-up study with oocyte donors exploring their experiences, knowledge, and attitudes about the use of their oocytes and the outcome of the donation. Fertil Steril (2000) 1.00
Responsible oversight of human stem cell research: the California Institute for Regenerative Medicine's medical and ethical standards. PLoS Med (2007) 0.97
Korean stem cell scandal. Schatten: Pitt panel finds 'misbehavior' but not misconduct. Science (2006) 0.96
Safety issues in cell-based intervention trials. Fertil Steril (2003) 0.96
A new era in the ethics of human embryonic stem cell research. Stem Cells (2005) 0.94
Adult versus embryonic stem cells: treatments. Science (2007) 0.90
The egg trade--making sense of the market for human oocytes. N Engl J Med (2007) 0.89
Clinical trials in stem cell transplantation: guidelines for scientific and ethical review. Clin Trials (2008) 0.86
Part-human chimeras: worrying the facts, probing the ethics. Am J Bioeth (2007) 0.85
Importing human pluripotent stem cell lines derived at another institution: tailoring review to ethical concerns. Cell Stem Cell (2009) 0.85
Response to open peer commentaries on "Thinking about the human neuron mouse". Am J Bioeth (2007) 0.83
The science and ethics of making part-human animals in stem cell biology. FASEB J (2006) 0.82
Human oocyte research: the ethics of donation and donor protection. JAMA (2008) 0.80
Scientific misconduct. Investigations document still more problems for stem cell researchers. Science (2006) 0.79
Establishing procedures for institutional oversight of stem cell research. Acad Med (2007) 0.78
The impact of web 2.0 on the doctor-patient relationship. J Law Med Ethics (2010) 1.09
Cloning mice and men: prohibiting the use of iPS cells for human reproductive cloning. Cell Stem Cell (2010) 0.91
Importing human pluripotent stem cell lines derived at another institution: tailoring review to ethical concerns. Cell Stem Cell (2009) 0.85
Resolving ethical issues in stem cell clinical trials: the example of Parkinson disease. J Law Med Ethics (2010) 0.79
Research ethics. NIH guidelines for stem cell research and gamete donors. Science (2010) 0.75